rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 16

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-00884 · 2004

Brain Opioids Produce Opposite Blood Pressure Effects in Lean Versus Obese Rats

ICV beta-endorphin decreased blood pressure in lean rats but increased it in diet-induced obese rats, with enhanced sympathetic activation and reduced vagal tone — demonstrating a fundamental opioid-cardiovascular control reversal in obesity.

Barnes, Maria J; Jen, K-L Catherine; Dunbar, Joseph C · Animal Study

RPEP-00886 · 2004

BPC-157 Protects Mice From Both Acute and Chronic Alcohol Damage

BPC-157 protected against acute ethanol toxicity (reduced mortality, behavioral impairment, gastric damage) and chronic alcohol effects (reduced intake, liver protection), demonstrating comprehensive anti-alcohol therapeutic potential.

Blagaic, Alenka Boban; Blagaic, Vladimir; Romic, Zeljko; Sikiric, Predrag · Animal Study

RPEP-00887 · 2004

Combined GHRP-2 + GHRH Sustainably Elevates GH and IGF-1 in Healthy Older Adults

Combined SC GHRP-2 + GHRH infusion sustainably elevated pulsatile GH, IGF-1, and IGFBP-3 in healthy older adults without desensitization, with synergy exceeding individual effects and women showing greater response than men.

Bowers, Cyril Y; Granda, Ramona; Mohan, Subburaman; Kuipers, Jonathan; Baylink, David; Veldhuis, Johannes D · Clinical Trial

RPEP-00897 · 2004

Ghrelin Inhibits New Blood Vessel Formation — The Opposite of What Cancer Researchers Feared

Ghrelin inhibited FGF-2-mediated angiogenesis: reduced endothelial cell proliferation, migration, tube formation in vitro, and new vessel formation in vivo — demonstrating anti-angiogenic rather than pro-angiogenic activity.

Conconi, Maria Teresa; Nico, Beatrice; Guidolin, Diego; Baiguera, Silvia; Spinazzi, Raffaella; Rebuffat, Piera; Malendowicz, Ludwik K; Vacca, Angelo; Carraro, Gianni; Parnigotto, Pier Paolo; Nussdorfer, Gastone G; Ribatti, Domenico · In Vitro

RPEP-00899 · 2004

Natriuretic Peptides Track Heart Stress During Infant Heart Surgery

BNP, ANP, and N-terminal ANP showed characteristic perioperative release patterns during infant cardiac surgery, with BNP best correlating with surgical cardiac stress — supporting neonatal/infant cardiac biomarker monitoring.

Costello, J M; Backer, C L; Checchia, P A; Mavroudis, C; Seipelt, R G; Goodman, D M · Cohort

RPEP-00901 · 2004

Measuring Satiety: Which Biomarkers Best Track the Feeling of Fullness

CCK and GLP-1 are the most validated satiety biomarkers correlating with both subjective appetite ratings and actual food intake, with PYY, ghrelin, insulin, and glucose providing complementary information in multi-marker panels.

de Graaf, Cees; Blom, Wendy A M; Smeets, Paul A M; Stafleu, Annette; Hendriks, Henk F J · Review

RPEP-00902 · 2004

Lactoferricin Blocks Dangerous Bacteria From Sticking to and Invading Human Cells

Bovine lactoferricin dose-dependently reduced Yersinia adhesion to and invasion of HEp-2 cells even at sub-bactericidal concentrations, demonstrating anti-virulence activity complementing its bactericidal effects.

Di Biase, Assunta Maria; Tinari, Antonella; Pietrantoni, Agostina; Antonini, Giovanni; Valenti, Piera; Conte, Maria Pia; Superti, Fabiana · In Vitro

RPEP-00903 · 2004

PT-141 Nasal Spray Safely Induces Erection in Both Healthy Men and ED Patients

Intranasal PT-141 induced dose-dependent erectile responses in both healthy men and Viagra-responsive ED patients in a double-blind, placebo-controlled trial, with rapid onset and acceptable safety — validating intranasal melanocortin ED therapy.

Diamond, L E; Earle, D C; Rosen, R C; Willett, M S; Molinoff, P B · RCT

RPEP-00904 · 2004

Ghrelin Has Anti-Inflammatory Effects: Suppressing Cytokines in Human Immune Cells

Ghrelin inhibited leptin-induced and activation-induced IL-1β, IL-6, and TNF-α production in human monocytes and T-cells through functional GHS-R on immune cells, establishing an anti-inflammatory role that opposes leptin's pro-inflammatory effects.

Dixit, Vishwa Deep; Schaffer, Eric M; Pyle, Robert S; Collins, Gary D; Sakthivel, Senthil K; Palaniappan, Ravichandran; Lillard, James W; Taub, Dennis D · Animal Study

RPEP-00905 · 2004

GHRP-2 Complete Pharmacology: GH Release, Appetite, Cardiovascular, and Clinical Applications

GHRP-2 (KP-102/pralmorelin) demonstrates potent GH-releasing activity through dual hypothalamic-pituitary mechanisms, with characterized appetite, cardiovascular, and diagnostic applications — a comprehensive pharmacological profile.

Doi, Naomi; Hirotani, Chiharu; Ukai, Kiyoharu; Shimada, Osafumi; Okuno, Tadashi; Kurasaki, Shigeru; Kiyofuji, Takeshi; Ikegami, Reiko; Futamata, Machiko; Nakagawa, Terutake; Ase, Katsuhiko; Chihara, Kazuo · Animal Study

RPEP-00908 · 2004

The Complete Neurohormonal Profile of Heart Failure: Natriuretic Peptides, Thyroid, Cytokines, and More

Heart failure involves coordinated dysregulation across natriuretic peptides, catecholamines, endothelin, thyroid hormones, and inflammatory cytokines, with multi-marker profiling providing comprehensive characterization beyond any single biomarker.

Emdin, Michele; Passino, Claudio; Prontera, Concetta; Iervasi, Annalisa; Ripoli, Andrea; Masini, Silvano; Zucchelli, Gian Carlo; Clerico, Aldo · Cohort

RPEP-00910 · 2004

Postmenopausal Women Need More GH Secretagogue Stimulation Even With Estrogen Replacement

Postmenopausal women, even with estradiol replacement, showed reduced fasting GH, IGF-1, and diminished dual-secretagogue GH burst response compared to premenopausal women — suggesting irreversible menopausal GH axis changes.

Erickson, Dana; Keenan, Daniel M; Mielke, Kristi; Bradford, Kandace; Bowers, Cyril Y; Miles, John M; Veldhuis, Johannes D · Clinical Trial

RPEP-00911 · 2004

BNP and ANP for Heart Failure: Diagnostic and Prognostic Performance Compared

BNP outperformed ANP for heart failure diagnosis (higher sensitivity/specificity) and prognosis, with NT-proBNP showing particularly strong prognostic value for predicting adverse cardiac events in LV systolic dysfunction.

Falcão, Luiz Menezes; Pinto, Fausto; Ravara, Luciano; van Zwieten, Peter Adriaan · Review

RPEP-00912 · 2004

Lactoferricin Peptides Bind Bacterial LPS and Kill E. coli Through Membrane Disruption

Lactoferricin-derived peptides bound bacterial LPS and showed antimicrobial activity against E. coli including LPS mutant strains, with activity correlating with LPS binding — confirming membrane interaction as the killing mechanism.

Farnaud, Sebastien; Spiller, Claire; Moriarty, Laura C; Patel, Alpesh; Gant, Vanya; Odell, Edward W; Evans, Robert W · In Vitro

RPEP-00914 · 2004

Spinal Cord Stimulation Releases Opioid Peptides in Patients With Limb Ischemia

Spinal cord stimulation in chronic critical limb ischemia patients increased CSF beta-endorphin levels, correlating with improved microvascular flow and wound healing — an endogenous opioid mechanism for SCS therapeutic effects.

Fontana, Fiorella; Bernardi, Pasquale; Lanfranchi, Giuseppina; Spampinato, Santi; Di Toro, Rosanna; Conti, Eleonora; Bonafè, Francesca; Coccheri, Sergio · Clinical Trial

RPEP-00918 · 2004

BNP Detects Hidden Heart Failure in Patients With Pacemakers

Natriuretic peptide levels identified LV dysfunction and comorbidities in pacemaker patients, supporting BNP measurement for detecting subclinical heart failure in cardiac device populations.

Gwechenberger, M; Huelsmann, M; Graf, S; Berger, R; Bonderman, D; Stanek, B; Rauscha, F; Pacher, R · Cross Sectional

RPEP-00920 · 2004

Novel Ghrelin Analogs: Longer-Acting and More Selective Versions for Clinical Use

Multiple novel ghrelin analogs were designed with improved pharmacokinetic properties (longer half-life, better stability) and selectivity profiles compared to native ghrelin, maintaining GH-releasing and appetite effects in animal models.

Halem, Heather A; Taylor, John E; Dong, Jesse Z; Shen, Yeelana; Datta, Rakesh; Abizaid, Alfonso; Diano, Sabrina; Horvath, Tamas; Zizzari, Philippe; Bluet-Pajot, Marie-Thèrèse; Epelbaum, Jacques; Culler, Michael D · Animal Study

RPEP-00921 · 2004

The Pharmacology of Human Appetite: From Leptin to GLP-1 to Drug Targets

Human appetite is regulated by a multi-level system including adiposity signals (leptin, insulin), gut peptides (GLP-1, PYY, CCK, ghrelin), and hypothalamic neuropeptides (NPY, AgRP, POMC), with GLP-1 and PYY identified as the most druggable targets.

Halford, Jason C G; Cooper, Gillian D; Dovey, Terence M · Review

RPEP-00923 · 2004

The Vagus Nerve Amplifies Ghrelin's Suppression After Eating Fat

Vagal stimulation amplified the inhibitory ghrelin response to oral fat in a human/animal model, demonstrating the vagus nerve acts as a gain controller for fat-induced ghrelin suppression — the gut-brain communication amplifying satiety.

Heath, R B; Jones, R; Frayn, K N; Robertson, M D · Animal Study

RPEP-00925 · 2004

Peripheral and Central Appetite Signals in Normal, Obese, and Binge-Eating People

Normal, obese, and binge-eating individuals show distinct patterns of appetite signal dysfunction across peripheral (gut peptides, adipokines) and central (hypothalamic neuropeptide) systems — disorder-specific signaling profiles enabling targeted treatment.

Hellström, Per M; Geliebter, Allan; Näslund, Erik; Schmidt, Peter T; Yahav, Eric K; Hashim, Sami A; Yeomans, Martin R · Review

RPEP-00926 · 2004

Enkephalin Neurons Map Onto the Social Behavior Brain Circuit in Hamsters

Met- and leu-enkephalin immunoreactive neurons were distributed throughout social behavior brain nuclei (BNST, medial amygdala, MPOA, lateral septum, PAG) in male hamsters, providing an anatomical framework for opioid peptide regulation of social and reproductive behaviors.

Holt, Avril Genene; Newman, Sarah Winans · Animal Study

RPEP-00927 · 2004

Optimizing Macrocyclic Ring Size for Peptide Deformylase Antibiotics

Ring size optimization of macrocyclic peptide deformylase inhibitors identified the most potent macrocycle dimensions, with X-ray crystallography confirming optimal binding geometry — advancing this bacteria-selective antibiotic mechanism.

Hu, Xubo; Nguyen, Kiet T; Jiang, Vernon C; Lofland, Denene; Moser, Heinz E; Pei, Dehua · In Vitro

RPEP-00928 · 2004

Heart Cells Make Their Own Ghrelin: A Local Cardiac Ghrelin System

Cardiomyocytes expressed ghrelin mRNA and protein, secreted ghrelin into culture medium, and expressed functional GHS-R — establishing an autocrine/paracrine cardiac ghrelin system for local cardiac regulation and protection.

Iglesias, María J; Piñeiro, Roberto; Blanco, Montserrat; Gallego, Rosalía; Diéguez, Carlos; Gualillo, Oreste; González-Juanatey, José R; Lago, Francisca · In Vitro

RPEP-00933 · 2004

Epithalon Peptide Helps Human Cells Overcome the Hayflick Division Limit

Epithalon peptide treatment enabled human somatic cells to overcome the Hayflick division limit (normally ~50 divisions), extending replicative lifespan through telomerase activation and telomere maintenance.

Khavinson, V Kh; Bondarev, I E; Butyugov, A A; Smirnova, T D · In Vitro

RPEP-00936 · 2004

Ghrelin: A Hormone With Multiple Functions Across Every Body System

Ghrelin demonstrates validated multi-system functions: GH release, appetite/adiposity control, cardiovascular protection, immune modulation, gastric motility regulation, and reproductive function — through GHS-R and non-GHS-R pathways in virtually every organ system.

Korbonits, Márta; Goldstone, Anthony P; Gueorguiev, Maria; Grossman, Ashley B · Review

RPEP-00939 · 2004

The Peptide Semax Protected Dopamine Neurons from Toxic Damage in a Rat Model of Parkinson's Disease

Daily intranasal administration of Semax (an ACTH(4-10) analog peptide, sequence MEHFPGP) at 0.2 mg/kg reduced the severity of behavioral disturbances caused by the neurotoxin MPTP in rats. MPTP selectively destroys dopamine neurons — the same neurons lost in Parkinson's disease — causing decreased movement and increased anxiety. Semax treatment lessened both of these deficits. The researchers proposed two mechanisms for Semax's protective effects: direct modulation of the dopaminergic system and broader neurotrophic (nerve-supporting) activity of the peptide.

Levitskaya, N G; Sebentsova, E A; Andreeva, L A; Alfeeva, L Yu; Kamenskii, A A; Myasoedov, N F · Animal

RPEP-00940 · 2004

Ghrelin Protects Blood Vessel Cells by Blocking Inflammation Through NF-κB Inhibition

Ghrelin inhibited TNF-α-induced VCAM-1, ICAM-1, and MCP-1 expression in human endothelial cells by blocking NF-κB nuclear translocation via IκBα preservation — a specific anti-inflammatory mechanism protecting blood vessels from atherosclerosis.

Li, Wei Gen; Gavrila, Dan; Liu, Xuebo; Wang, Lixing; Gunnlaugsson, Skuli; Stoll, Lynn L; McCormick, Michael L; Sigmund, Curt D; Tang, Chaosu; Weintraub, Neal L · In Vitro

RPEP-00941 · 2004

Thymalfasin for Chronic Hepatitis B: Clinical Evidence Review

Thymalfasin achieved sustained HBV virological response with increasing durability over follow-up and minimal side effects, positioning it as a well-tolerated immune-based alternative for chronic hepatitis B treatment.

Liaw, Yun-Fan · Review

RPEP-00942 · 2004

Ghrelin Gene Regulation and Appetite Effects Differ Between Rat Strains

Gastric ghrelin gene expression regulation and feeding response to ghrelin analog differed between lean (Fischer 344) and obesity-prone (Sprague-Dawley) rats, demonstrating genetic/strain variability in ghrelin biology.

Liu, Xiaotuan; York, David A; Bray, George A · Animal Study

RPEP-00943 · 2004

Lactoferricin Blocks Early Steps of Listeria Infection in Human Immune Cells

Lactoferricin inhibited Listeria monocytogenes adhesion to and internalization by THP-1 human macrophages, reducing early infection events beyond direct bacterial killing — demonstrating anti-virulence protection.

Longhi, Catia; Conte, Maria P; Penta, Michela; Cossu, Alessia; Antonini, Giovanni; Superti, Fabiana; Seganti, Lucilla · In Vitro

RPEP-00944 · 2004

BPC-157 Reverses Doxorubicin-Induced Heart Failure and Big Endothelin-1 Elevation in Rats

BPC-157 reversed doxorubicin-induced CHF signs and normalized elevated Big Endothelin-1 levels in rats, comparable to amlodipine and losartan — demonstrating cardioprotective peptide activity against chemotherapy-induced cardiomyopathy.

Lovric-Bencic, Martina; Sikiric, Predrag; Hanzevacki, Jadranka S; Seiwerth, Sven; Rogic, Dunja; Kusec, Vesna; Aralica, Gorana; Konjevoda, Pasko; Batelja, Lovorka; Blagaic, Alenka B · Animal Study